Approaches to Study Native Chromatin-Modifying Complex Activities and Functions.

chromatin histone modification native protein complexes nuclear protein depletion recombinant nucleosomes

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2021
Historique:
received: 23 06 2021
accepted: 24 08 2021
entrez: 4 10 2021
pubmed: 5 10 2021
medline: 5 10 2021
Statut: epublish

Résumé

The modification of histones-the structural components of chromatin-is a central topic in research efforts to understand the mechanisms regulating genome expression and stability. These modifications frequently occur through associations with multisubunit complexes, which contain active enzymes and additional components that orient their specificity and read the histone modifications that comprise epigenetic signatures. To understand the functions of these modifications it is critical to study the enzymes and substrates involved in their native contexts. Here, we describe experimental approaches to purify native chromatin modifiers complexes from mammalian cells and to produce recombinant nucleosomes that are used as substrates to determine the activity of the complex. In addition, we present a novel approach, similar to the yeast anchor-away system, to study the functions of essential chromatin modifiers by quickly inducing their depletion from the nucleus. The step-by-step protocols included will help standardize these approaches in the research community, enabling convincing conclusions about the specificities and functions of these crucial regulators of the eukaryotic genome.

Identifiants

pubmed: 34604228
doi: 10.3389/fcell.2021.729338
pmc: PMC8481805
doi:

Types de publication

Journal Article

Langues

eng

Pagination

729338

Informations de copyright

Copyright © 2021 Galloy, Lachance, Cheng, Distéfano-Gagné, Côté and Fradet-Turcotte.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Mol Biol. 1999 Apr 30;288(2):213-29
pubmed: 10329138
Nucleic Acids Res. 2020 Oct 9;48(18):e108
pubmed: 32941625
Sci Signal. 2011 Mar 15;4(164):rs2
pubmed: 21406691
Methods Enzymol. 2004;375:228-38
pubmed: 14870670
Methods Enzymol. 1996;274:276-91
pubmed: 8902812
Elife. 2020 Jun 16;9:
pubmed: 32543371
Nat Commun. 2020 Nov 11;11(1):5701
pubmed: 33177522
Nat Biotechnol. 2009 Sep;27(9):851-7
pubmed: 19680244
Nat Rev Cancer. 2011 Dec 01;12(1):51-8
pubmed: 22129804
EMBO J. 2016 Jan 18;35(2):176-92
pubmed: 26620551
J Mol Biol. 1998 Feb 13;276(1):19-42
pubmed: 9514715
Nat Biotechnol. 1999 Oct;17(10):1030-2
pubmed: 10504710
Nat Methods. 2013 Aug;10(8):715-21
pubmed: 23900254
Mol Cell. 2016 May 5;62(3):409-421
pubmed: 27153538
Curr Protoc Mol Biol. 2010 Apr;Chapter 21:Unit 21.18.1-10
pubmed: 20373501
Genes Dev. 2014 May 15;28(10):1029-41
pubmed: 24831698
Methods. 2001 Jul;24(3):218-29
pubmed: 11403571
Cancer Cell. 2016 Apr 11;29(4):464-476
pubmed: 27070701
Mol Cell. 2008 Sep 26;31(6):925-32
pubmed: 18922474
Methods Enzymol. 2016;573:303-18
pubmed: 27372759
Methods Enzymol. 2016;573:67-96
pubmed: 27372749
Nat Rev Genet. 2016 Aug;17(8):487-500
pubmed: 27346641
Methods Enzymol. 2004;375:23-44
pubmed: 14870657
Cell Rep. 2015 Oct 20;13(3):621-633
pubmed: 26456817
Dev Dyn. 2009 Nov;238(11):2912-21
pubmed: 19842187
Nat Struct Mol Biol. 2009 Feb;16(2):151-8
pubmed: 19182801
Nat Commun. 2018 Apr 11;9(1):1394
pubmed: 29643390
Mol Cell. 2018 Feb 1;69(3):385-397.e8
pubmed: 29336876
Nat Chem Biol. 2018 May;14(5):431-441
pubmed: 29581585
Genome Res. 2010 Aug;20(8):1133-42
pubmed: 20508142
Curr Protoc Mol Biol. 2001 May;Chapter 21:Unit 21.5
pubmed: 18265197
Cell. 2000 Aug 18;102(4):463-73
pubmed: 10966108
Curr Protoc Mol Biol. 2006 Aug;Chapter 12:Unit 12.1
pubmed: 18265374
Mol Cell Biol. 2004 Mar;24(5):1884-96
pubmed: 14966270
Am J Pathol. 2013 Jan;182(1):152-62
pubmed: 23159946
Mol Cell. 2010 Jan 15;37(1):57-66
pubmed: 20129055
Nature. 2008 Jun 5;453(7196):812-6
pubmed: 18449190
Mol Cell Biol. 2013 Jan;33(1):159-69
pubmed: 23109429
Cell. 2008 Jul 11;134(1):162-74
pubmed: 18614019
Cell. 2013 Mar 28;153(1):38-55
pubmed: 23540689
Mol Cell. 2006 Jan 6;21(1):51-64
pubmed: 16387653
Nat Methods. 2011 Aug 21;8(10):861-9
pubmed: 21857672
J Biochem Biophys Methods. 2001 Oct 30;49(1-3):455-65
pubmed: 11694294
Methods Enzymol. 2016;573:3-41
pubmed: 27372747
Nat Struct Mol Biol. 2018 Feb;25(2):154-162
pubmed: 29379173
Mol Cell. 2019 Jun 6;74(5):862-863
pubmed: 31173720
Nat Commun. 2020 Nov 20;11(1):5913
pubmed: 33219211
Nature. 2020 Mar;579(7799):448-451
pubmed: 32188943
Blood. 2020 Oct 8;136(15):1735-1747
pubmed: 32542325
Elife. 2019 Dec 30;8:
pubmed: 31886770
Nature. 2007 Aug 30;448(7157):1063-7
pubmed: 17728759
Science. 2017 Apr 14;356(6334):205-208
pubmed: 28408607
Front Genet. 2015 Feb 03;6:19
pubmed: 25691891
Nat Struct Mol Biol. 2020 Jan;27(1):8-13
pubmed: 31819277

Auteurs

Maxime Galloy (M)

St-Patrick Research Group in Basic Oncology, Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Québec, QC, Canada.
Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Université Laval, Québec, QC, Canada.

Catherine Lachance (C)

St-Patrick Research Group in Basic Oncology, Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Québec, QC, Canada.
Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Université Laval, Québec, QC, Canada.

Xue Cheng (X)

St-Patrick Research Group in Basic Oncology, Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Québec, QC, Canada.
Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Université Laval, Québec, QC, Canada.

Félix Distéfano-Gagné (F)

St-Patrick Research Group in Basic Oncology, Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Québec, QC, Canada.
Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Université Laval, Québec, QC, Canada.

Jacques Côté (J)

St-Patrick Research Group in Basic Oncology, Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Québec, QC, Canada.
Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Université Laval, Québec, QC, Canada.

Amelie Fradet-Turcotte (A)

St-Patrick Research Group in Basic Oncology, Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Québec, QC, Canada.
Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Université Laval, Québec, QC, Canada.

Classifications MeSH